安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- NIH launches clinical trial of Epstein-Barr virus vaccine
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has launched an early-stage clinical trial to evaluate an investigational preventative vaccine for Epstein-Barr virus (EBV)
- Epstein–Barr virus vaccine - Wikipedia
As of 2024, a vaccine against Epstein–Barr virus was not yet available [1] [2] The virus establishes latent infection and causes infectious mononucleosis There is also increasingly more evidence that EBV may be a trigger of multiple sclerosis [3]
- First-Ever Vaccine Candidate Against Epstein-Barr . . . - ScienceAlert
Researchers have made a significant breakthrough in the development of the first-ever vaccine for the Epstein-Barr virus (EBV), a virus that causes infectious mononucleosis (IM, or 'mono') – also known as glandular fever
- Epstein-Barr virus: New vaccine may reduce risk of MS, various cancers
Researchers developed a groundbreaking vaccine for the Epstein-Barr virus (EBV), which is linked to a 32-fold higher risk of multiple sclerosis (MS)
- Therapeutic vaccines for Epstein–Barr virus: a way forward
There is no approved therapeutic vaccine for Epstein–Barr virus An increasing number of therapeutic vaccines for Epstein–Barr virus have been developed for the treatment of Epstein–Barr virus-associated malignancies, especially nasopharyngeal carcinoma
- Epstein-Barr virus vaccine | EBSCO Research Starters
Research into an EBV vaccine is ongoing, with glycoprotein 350 (gp350) identified as a promising target This glycoprotein plays a critical role in the virus's ability to enter human cells and elicits a significant immune response
- Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for . . .
Therapeutic EBV vaccines have also been tested clinically with encouraging results Immunization with various vaccine platforms expressing the EBV latent proteins EBNA1, LMP1, and or LMP2 promoted specific CD4+ and CD8+ cytotoxic responses with anti-tumor activity
- Researchers advance development of potential Epstein-Barr virus vaccines
Fred Hutch researcher Dr Andrew McGuire and his team report encouraging results in early laboratory test of a new concept in vaccines for Epstein-Barr virus, the bug that not only causes mononucleosis, but is implicated in several cancers and more recently, for triggering multiple sclerosis
|
|
|